Möchten Sie immer auf dem neuesten Stand bleiben?

Everett, Washington, March 18, 2026 (GLOBE NEWSWIRE) -- Fluke Corporation today announced the SmartTrace™ 2082 Series of Underground Locators, the Company’s new underground utilities locator...

AUSTIN, Texas, March 18, 2026 (GLOBE NEWSWIRE) -- Iteris, Inc., the world’s trusted technology ecosystem for smart mobility infrastructure management and part of the Almaviva Group, today announced...

Plum launches Explorer SR Mini, a compact, self-powered broadband kit with dual 5G and Starlink connectivity for anywhere communications.

SAN FRANCISCO, March 18, 2026 (GLOBE NEWSWIRE) -- Private markets have no shortage of benchmarks, but each one is built on closed deal data that arrives months after transactions close. None can...

Fullstory, a leading behavioral data company, today announced significant company acceleration and major product innovations in its second half.

MACOM to showcase its latest RF and optoelectronics solutions for satellite communications at Booth 1637, during SATShow Week.

Tarrytown, New York, USA, March 18, 2026 (GLOBE NEWSWIRE) -- Research assays help generate evidence about whether biomarkers can advance disease managementNovel RUO tests can help scientists...

Additional biomarker analysis reveals higher CSF levels of DOPA decarboxylase (DDC – an emerging PD biomarker) at baseline with a reduction following 90 days of dosing with GT-02287 in individuals...

Aclaris Therapeutics Completes Enrollment in Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis

The 7 mg dose of OV329 demonstrated favorable safety and tolerability profile, reinforcing best-in-category potential for refractory epilepsies; Ovid advancing plans to initiate a Phase 2 trial in...